nChroma Bio logo

nChroma Bio

Healthcare & Life Sciences

Recent Finacing

Equity

Recent Raise

$75M


nChroma Bio develops innovative genetic medicines using epigenetic editing and non-viral delivery technologies to treat chronic hepatitis B and D.

Total Funding

$75M

Headquarters

Boston, USA

Founded

N/A

Focus Areas

Epigenetic editing
Genetic medicines
Non-viral delivery
Liver-targeted therapy
Chronic hepatitis B and D
Programmable tissue specificity

Investors